These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4729904)

  • 21. Cholesterol lowering bile acid binding agents: novel lipophilic polyamines.
    Thomas EW; Cudahy MM; Spilman CH; Dinh DM; Watkins TL; Vidmar TJ
    J Med Chem; 1992 Apr; 35(7):1233-45. PubMed ID: 1560437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of cholestyramine on thyroxine absorption.
    Northcutt RC; Stiel JN; Hollifield JW; Stant EG
    JAMA; 1969 Jun; 208(10):1857-61. PubMed ID: 5818830
    [No Abstract]   [Full Text] [Related]  

  • 23. Colestipol and clofibrate in hypercholesterolemia.
    Dujovne CA; Hurwitz A; Kauffman RE; Azarnoff DL
    Clin Pharmacol Ther; 1974 Aug; 16(2):291-6. PubMed ID: 4604239
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of pH changes and ethanol on the binding of tricyclic antidepressants to cholestyramine in simulated gastric fluid.
    Bailey DN
    Ther Drug Monit; 1992 Aug; 14(4):343-6. PubMed ID: 1519311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide.
    Neuvonen PJ; Kivistö K; Hirvisalo EL
    Br J Clin Pharmacol; 1988 Feb; 25(2):229-33. PubMed ID: 3358884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired absorption of tetracycline by colestipol is not reversed by orange juice.
    Friedman H; Greenblatt DJ; LeDuc BW
    J Clin Pharmacol; 1989 Aug; 29(8):748-51. PubMed ID: 2778097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cholestyramine and colestipol on the plasma concentrations of propranolol.
    Hibbard DM; Peters JR; Hunninghake DB
    Br J Clin Pharmacol; 1984 Sep; 18(3):337-42. PubMed ID: 6487473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acceptability of cholestyramine or colestipol combinations with six vehicles.
    Shaefer MS; Jungnickel PW; Jacobs EW; Maloley PA
    Clin Pharm; 1987 Jan; 6(1):51-4. PubMed ID: 3816107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term treatment of hypercholesterolemia with colestipol hydrochloride.
    Ryan JR; Jain AK; McMahon FG
    Clin Pharmacol Ther; 1975 Jan; 17(1):83-7. PubMed ID: 1091391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction between cholestyramine and drugs.
    Gallo DG; Bailey KR; Sheffner AL
    Proc Soc Exp Biol Med; 1965 Oct; 120(1):60-5. PubMed ID: 5852732
    [No Abstract]   [Full Text] [Related]  

  • 31. Binding of bile salts in vitro by nonnutritive fiber.
    Kritchevsky D; Story JA
    J Nutr; 1974 Apr; 104(4):458-62. PubMed ID: 4816931
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of cholestyramine on the gastrointestinal absorption of phenprocoumon and acetylosalicylic acid in man.
    Hahn KJ; Eiden W; Schettle M; Hahn M; Walter E; Weber E
    Eur J Clin Pharmacol; 1972 Jun; 4(3):142-5. PubMed ID: 4655288
    [No Abstract]   [Full Text] [Related]  

  • 33. A controlled clinical trial of cholestyramine in the treatment of gastric ulcer.
    Black RB; Rhodes J; Davies GT; Gravelle H; Sweetnam P
    Gastroenterology; 1971 Dec; 61(6):821-5. PubMed ID: 5125683
    [No Abstract]   [Full Text] [Related]  

  • 34. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent.
    Nye ER; Jackson D; Hunter JD
    N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110
    [No Abstract]   [Full Text] [Related]  

  • 36. Response of hyperlipoproteinemia to colestipol.
    Sachs BA; Wolfman L
    N Y State J Med; 1973 May; 73(9):1068-70. PubMed ID: 4512165
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of cholestyramine and colestipol on the absorption of diclofenac in man.
    al-Balla SR; el-Sayed YM; al-Meshal MA; Gouda MW
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):441-5. PubMed ID: 7981930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlorothiazide absorption in humans--possible example of Michaelis-Menten kinetics.
    Adebayo GI; Mabadeje AF
    Pharmacology; 1985; 31(4):181-8. PubMed ID: 4059322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 99m Tc-pertechnetate transport in man: absorption after subcutaneous and oral administration; secretion into saliva and gastric juice.
    Hays MT
    J Nucl Med; 1973 Jun; 14(6):331-5. PubMed ID: 4701830
    [No Abstract]   [Full Text] [Related]  

  • 40. Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Mar; 19(3):161-80. PubMed ID: 6988203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.